Literature DB >> 19149990

Head-to-head comparison of two first-line regimens and an NRTI-sparing regimen for initial therapy of HIV-1 infection: what should we start?

David L Pitrak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19149990     DOI： 10.1007/s11904-009-0001-4

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


× No keyword cloud information.
  3 in total

1.  Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.

Authors:  S A Mallal; M John; C B Moore; I R James; E J McKinnon
Journal:  AIDS       Date:  2000-07-07       Impact factor: 4.177

2.  A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

Authors:  A Carr; J Miller; M Law; D A Cooper
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

3.  Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival.

Authors:  S R Vlahakis; G D Bren; A Algeciras-Schimnich; S A Trushin; D J Schnepple; A D Badley
Journal:  Clin Pharmacol Ther       Date:  2007-03-14       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.